124,383 Shares in DocGo Inc. (NASDAQ:DCGO) Purchased by Raymond James Financial Inc.

Raymond James Financial Inc. acquired a new position in shares of DocGo Inc. (NASDAQ:DCGO - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 124,383 shares of the company's stock, valued at approximately $527,000. Raymond James Financial Inc. owned about 0.12% of DocGo as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in DCGO. Barclays PLC boosted its position in shares of DocGo by 279.7% during the 3rd quarter. Barclays PLC now owns 134,923 shares of the company's stock worth $447,000 after acquiring an additional 99,387 shares in the last quarter. Franklin Resources Inc. boosted its stake in shares of DocGo by 11.6% in the 3rd quarter. Franklin Resources Inc. now owns 1,199,086 shares of the company's stock valued at $3,933,000 after purchasing an additional 124,348 shares during the last quarter. JPMorgan Chase & Co. grew its stake in DocGo by 151.1% during the third quarter. JPMorgan Chase & Co. now owns 109,855 shares of the company's stock worth $365,000 after purchasing an additional 66,097 shares during the period. Harbor Capital Advisors Inc. increased its stake in shares of DocGo by 37.5% in the 4th quarter. Harbor Capital Advisors Inc. now owns 1,331,928 shares of the company's stock valued at $5,647,000 after acquiring an additional 363,391 shares in the last quarter. Finally, SG Americas Securities LLC grew its stake in DocGo by 12.9% in the fourth quarter. SG Americas Securities LLC now owns 43,052 shares of the company's stock valued at $183,000 after acquiring an additional 4,905 shares during the period. Institutional investors own 56.44% of the company's stock.

DocGo Stock Down 39.5 %

Shares of DocGo stock traded down $0.92 during trading hours on Friday, reaching $1.41. 9,518,179 shares of the stock traded hands, compared to its average volume of 763,955. DocGo Inc. has a one year low of $1.39 and a one year high of $5.68. The firm has a market capitalization of $143.80 million, a price-to-earnings ratio of 5.04, a P/E/G ratio of 14.16 and a beta of 1.14. The company has a 50 day moving average price of $2.52 and a 200 day moving average price of $3.68.

DocGo (NASDAQ:DCGO - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.08). DocGo had a return on equity of 8.90% and a net margin of 4.35%. Sell-side analysts anticipate that DocGo Inc. will post 0.25 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on DCGO shares. Stifel Nicolaus reduced their target price on DocGo from $6.50 to $5.50 and set a "buy" rating for the company in a report on Friday, February 28th. Needham & Company LLC cut their price target on DocGo from $4.00 to $3.00 and set a "buy" rating for the company in a report on Friday. Deutsche Bank Aktiengesellschaft cut shares of DocGo from a "buy" rating to a "hold" rating and lowered their target price for the stock from $5.00 to $2.85 in a research note on Friday, February 28th. Finally, BTIG Research lowered shares of DocGo from a "buy" rating to a "neutral" rating in a research report on Friday. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $4.09.

DocGo Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.